San Diego, CA, United States of America

Jeffrey S Hall

This inventor holds 26 USPTO granted patents and 17 published patent applications and 1 EPO patent, primarily in Pharmaceutical Manufacturing. Top assignees: Pacira Pharmaceuticals, Inc., Other. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey S Hall. Retrieved from https://idiyas.com/inventor/jeffrey-s-hall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 88.5

 

Average Co-Inventor Count = 4.6

ph-index = 11

Forward Citations = 268(Granted Patents)


Location History:

  • North Kingstown, RI (US) (2006)
  • San Diego, CA (US) (2021 - 2024)

Company Filing History:

goldMedal24 out of 60 
 
Pacira Pharmaceuticals, Inc.
 patents
silverMedal1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Bupivacaine
Multivesicular Liposomes
Pharmaceuticals
Compositions
Sleep Apnea
Manufacturing
Drug Delivery
Formulations
Therapeutics
Liposome Technology
Medical Devices
26 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Jeffrey S. Hall

Introduction

Jeffrey S. Hall is an esteemed inventor residing in San Diego, California. With an impressive portfolio of 16 patents, Hall has made significant contributions to the field of pharmaceuticals, particularly in the development of bupivacaine multivesicular liposomes. His innovative work has enhanced manufacturing processes and improved product stability, paving the way for advancements in medical applications.

Latest Patents

Among his latest patents, Hall has focused on the manufacturing of bupivacaine multivesicular liposomes (MVLs). One of his notable patents details a commercial manufacturing process utilizing independently operating dual tangential flow filtration modules. This method not only optimizes the production of MVLs but also ensures high yields and desired particle size distributions. Another patent outlines a new large-scale commercial process that enhances the stability and overall quality of bupivacaine MVLs, showcasing Hall's dedication to improving pharmaceutical manufacturing.

Career Highlights

Jeffrey S. Hall currently works at Pacira Pharmaceuticals, Inc., where he continues to drive innovation in drug formulation and delivery systems. His work has positioned the company at the forefront of advanced pharmaceutical solutions, demonstrating his commitment to enhancing patient care through innovative technologies.

Collaborations

Throughout his career, Hall has collaborated with notable figures including John J. Grigsby, Jr. and David J. Turnbull. These partnerships have fostered an environment of creativity and progression, as they work together to address complex challenges in pharmaceutical development.

Conclusion

Jeffrey S. Hall’s contributions to the field of pharmaceuticals through his inventions and patents underscore his status as a leading inventor. His work at Pacira Pharmaceuticals, Inc. not only enhances drug manufacturing processes but also exemplifies the potential for innovation to improve healthcare outcomes. As he continues to create and innovate, the impact of his work will resonate within the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…